Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Treating cancer deficient in FANCA, FANCD2, FANCE, or FANCG with an ATM inhibitor

Treating cancer deficient in FANCA, FANCD2, FANCE, or FANCG with an ATM inhibitor

US Patent 10738310 · Granted Aug 11, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods of treating cancers having a BRCA1 and/or BRCA2 mutation(s)2025
Compounds and methods for treating cancer2025
Curb sweeper apparatus for blade-carrying machines2024
Methods and materials for using measles viruses2024
Safety equipment2024
Compositions and methods of treating Fanconi Anemia2023
Therapeutic compositions, combinations, and methods of use2023
Methods for enhancing the efficiency of gene editing2022
Methods for enhancing the efficiency of gene editing2022
Methods of treating cancers2022
Gene signature for immune therapies in cancer2022
Compounds and methods for treating cancer2022